** Shares of Pacific Edge NZX:PEB down 5.5% at NZ$0.171, set for their weakest session since mid-September, if current trend holds
** The cancer diagnostics company posts first-half 2026 net loss after tax of NZ$19.1 million ($10.72 million), versus loss of NZ$14.5 million from a year before
** Adds that first-half total operating revenue at NZ$5.9 million versus NZ$11 million last year
** About 1.9 million shares change hands, 4.1x the 30-day average
** YTD, stock up 36.8%, including the day's move
($1 = 1.7809 New Zealand dollars)